{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Park KH"],"funding":["Korea Centers for Disease Control & Prevention","Korea Centers for Disease Control &amp; Prevention","Chosun University Hospital"],"pagination":["350-365"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8925943"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["37(2)"],"pubmed_abstract":["<h4>Background/aims</h4>While switching strategies of P2Y12 receptor inhibitors (RIs) have sometimes been used in acute myocardial infarction (AMI) patients, the current status of in-hospital P2Y12RI switching remains unknown.<h4>Methods</h4>Overall, 8,476 AMI patients who underwent successful revascularization from Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH) were divided according to in-hospital P2Y12RI strategies, and net adverse cardiovascular events (NACEs), defined as a composite of cardiac death, non-fatal myocardial infarction (MI), stroke, or thrombolysis in myocardial infarction (TIMI) major bleeding during hospitalization were compared.<h4>Results</h4>Patients with in-hospital P2Y12RI switching accounted for 16.5%, of which 867 patients wer"],"journal":["The Korean journal of internal medicine"],"pubmed_title":["The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction."],"pmcid":["PMC8925943"],"funding_grant_id":["2016-ER6304-02"],"pubmed_authors":["Seung KB","Park KH","Kim SS","Ahn Y","Rha SW","Kim CJ","Oh SK","Joo SJ","Chae SC","Hwang JY","Kim HK","Ki YJ","Choi DJ","Kim DI","Chae JK","Seong IW","KAMIR-NIH registry investigators","Kim HS","Yoon JH","Cho MC","Park JS","Hur SH","Gwon HC","Cha KS","Ahn TH","Kook HY","Jeong MH"],"additional_accession":[]},"is_claimable":false,"name":"The current status and outcomes of in-hospital P2Y12 receptor inhibitor switching in Korean patients with acute myocardial infarction.","description":"<h4>Background/aims</h4>While switching strategies of P2Y12 receptor inhibitors (RIs) have sometimes been used in acute myocardial infarction (AMI) patients, the current status of in-hospital P2Y12RI switching remains unknown.<h4>Methods</h4>Overall, 8,476 AMI patients who underwent successful revascularization from Korea Acute Myocardial Infarction Registry-National Institute of Health (KAMIR-NIH) were divided according to in-hospital P2Y12RI strategies, and net adverse cardiovascular events (NACEs), defined as a composite of cardiac death, non-fatal myocardial infarction (MI), stroke, or thrombolysis in myocardial infarction (TIMI) major bleeding during hospitalization were compared.<h4>Results</h4>Patients with in-hospital P2Y12RI switching accounted for 16.5%, of which 867 patients wer","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Mar","modification":"2025-04-05T11:07:34.702Z","creation":"2025-04-05T11:07:34.702Z"},"accession":"S-EPMC8925943","cross_references":{"pubmed":["35016269"],"doi":["10.3904/kjim.2021.101"]}}